Vimarsana
Biggest News Aggregation in the World

Page 31 - Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Get Rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Get Rating Today - Breaking & Trending Today

Comparing Cochlear (CHEOF) & Its Peers - Vimarsana News

Comparing Cochlear (CHEOF) & Its Peers

Cochlear (OTCMKTS:CHEOF – Get Rating) is one of 121 public companies in the “Medical Devices” industry, but how does it contrast to its competitors? We will compare Cochlear to similar businesses based on the strength of its profitability, institutional ownership, dividends, risk, valuation, analyst recommendations and earnings. Analyst Recommendations This is a summary of recent […]

Fortress Biotech, Inc. (NASDAQ:FBIO) Given Consensus Rating of "Buy" by Brokerages - Vimarsana News

Fortress Biotech, Inc. (NASDAQ:FBIO) Given Consensus Rating of "Buy" by Brokerages

Fortress Biotech, Inc. (NASDAQ:FBIO – Get Rating) has been given an average recommendation of “Buy” by the five analysts that are currently covering the company, MarketBeat reports. Five research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued a report on the stock in […]

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated at StockNews.com - Vimarsana News

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Performance NYSEAMERICAN AMPE opened at $0.24 on Friday. The stock has a 50 day moving average price of $0.25 and a […]

Ligand Pharmaceuticals (NASDAQ:LGND) Lifted to "Buy" at StockNews.com - Vimarsana News

Ligand Pharmaceuticals (NASDAQ:LGND) Lifted to "Buy" at StockNews.com

StockNews.com upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Saturday. A number of other brokerages have also commented on LGND. HC Wainwright raised their price target on Ligand Pharmaceuticals from $135.00 to $144.00 in a research note on […]

East Africa Metals (CVE:EAM) Trading 9.5% Higher - Vimarsana News

East Africa Metals (CVE:EAM) Trading 9.5% Higher

Shares of East Africa Metals Inc. (CVE:EAM – Get Rating) traded up 9.5% during trading on Tuesday . The stock traded as high as C$0.12 and last traded at C$0.12. 14,500 shares were traded during mid-day trading, a decline of 49% from the average session volume of 28,567 shares. The stock had previously closed at […]